Literature DB >> 24133930

Provision of antiretroviral care to displaced populations in humanitarian settings: a systematic review.

Karolina Griffiths1, Nathan Ford.   

Abstract

Providing antiretroviral treatment (ART) in humanitarian settings is challenging. Reports suggest that ART provision is feasible, but the evidence base is scarce. We systematically searched three databases for studies reporting ART outcomes among displaced populations in settings of conflict, natural disasters or political instability, and estimated overall mortality using random effects models. Fourteen studies were identified, six in conflict areas, five in areas of post-election violence and three in natural disaster settings. The pooled proportion for mortality was 7.6% (95% CI 5.3-10.0%) at six months and 9.0% (95% CI 5.8-12.2%) at 12 months. Loss-to-follow-up at six months was 6.3% (95% CI 4.3-8.3%) and at 12 months was 8.1% (4.9-11.2%). Adherence was comparable to stable settings. Strategies used to support ART provision included additional drug stocks and establishing peer communication networks. Good clinical outcomes can be achieved with ART in disaster setting, in particular if supported by regional collaboration, standardized drug regimens and contingency planning.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24133930     DOI: 10.1080/13623699.2013.813108

Source DB:  PubMed          Journal:  Med Confl Surviv        ISSN: 1362-3699


  5 in total

Review 1.  Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needs.

Authors:  Charles Ssonko; Lucia Gonzalez; Anita Mesic; Marcio Silveira da Fonseca; Jay Achar; Nadia Safar; Beatriz Martin; Sidney Wong; Esther C Casas
Journal:  J Int AIDS Soc       Date:  2017-07-21       Impact factor: 5.396

2.  Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp.

Authors:  Joshua B Mendelsohn; Paul Spiegel; Alison Grant; Sathyanarayanan Doraiswamy; Marian Schilperoord; Natasha Larke; John Wagacha Burton; Jully A Okonji; Clement Zeh; Bosco Muhindo; Ibrahim M Mohammed; Irene N Mukui; Njogu Patterson; Egbert Sondorp; David A Ross
Journal:  Confl Health       Date:  2017-05-31       Impact factor: 2.723

3.  Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.

Authors:  Suraj A Abdullahi; Marina Smelyanskaya; Stephen John; Haruna I Adamu; Emperor Ubochioma; Ishaya Kennedy; Fatima A Abubakar; Haruna A Ago; Robert Stevens; Jacob Creswell
Journal:  PLoS Med       Date:  2020-09-09       Impact factor: 11.069

4.  Determinants of Survival of HIV Patients Receiving Dolutegravir: A Prospective Cohort Study in Conflict-Affected Bunia, Democratic Republic of Congo.

Authors:  Roger T Buju; Pierre Z Akilimali; Nguyen-Toan Tran; Erick N Kamangu; Gauthier K Mesia; Jean Marie N Kayembe; Hippolyte N Situakibanza
Journal:  Int J Environ Res Public Health       Date:  2022-08-17       Impact factor: 4.614

5.  What drives mortality among HIV patients in a conflict setting? A prospective cohort study in the Central African Republic.

Authors:  Thomas Crellen; Charles Ssonko; Turid Piening; Marcel Mbeko Simaleko; Karen Geiger; M Ruby Siddiqui
Journal:  Confl Health       Date:  2019-11-14       Impact factor: 2.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.